Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids
about
Translational biomarkers of neurotoxicity: a Health and Environmental Sciences Institute perspective on the way forwardPredicting, preventing, and identifying delirium after cardiac surgeryDevelopment of prognostic models for patients with traumatic brain injury: a systematic reviewSystems biology approaches for discovering biomarkers for traumatic brain injuryIdentification of serum microRNA signatures for diagnosis of mild traumatic brain injury in a closed head injury model.Fluid Biomarkers of Traumatic Brain Injury and Intended Context of UsePotential Blood-based Biomarkers for Concussion.Biomarkers and acute brain injuries: interest and limitsSerial Sampling of Serum Protein Biomarkers for Monitoring Human Traumatic Brain Injury Dynamics: A Systematic Review.Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention.Ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) is increased in cerebrospinal fluid and plasma of patients after epileptic seizureHuman traumatic brain injury induces autoantibody response against glial fibrillary acidic protein and its breakdown products.Ubiquitin carboxy-terminal hydrolase-l1 as a serum neurotrauma biomarker for exposure to occupational low-level blastComparative Assessment of the Prognostic Value of Biomarkers in Traumatic Brain Injury Reveals an Independent Role for Serum Levels of Neurofilament LightTemporal MRI characterization, neurobiochemical and neurobehavioral changes in a mouse repetitive concussive head injury model.Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury.Serum UCH-L1 as a Novel Biomarker to Predict Neuronal Apoptosis Following Deep Hypothermic Circulatory Arrest.Interferon-Stimulated Gene 15 Upregulation Precedes the Development of Blood-Brain Barrier Disruption and Cerebral Edema after Traumatic Brain Injury in Young Mice.Glial neuronal ratio: a novel index for differentiating injury type in patients with severe traumatic brain injury.Translating basic science research to clinical application: models and strategies for intracerebral hemorrhage.The diagnosis of traumatic brain injury on the battlefield.Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator.Glial Fibrillary Acidic Protein Is Not an Early Marker of Injury in Perinatal Asphyxia and Hypoxic-Ischemic Encephalopathy.Therapy development for diffuse axonal injury.Assessment of Serum UCH-L1 and GFAP in Acute Stroke Patients.A military-centered approach to neuroprotection for traumatic brain injury.Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain InjuryPlasma Anti-Glial Fibrillary Acidic Protein Autoantibody Levels during the Acute and Chronic Phases of Traumatic Brain Injury: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot Study.Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein.A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury.Biomarkers in traumatic brain injury.Biomarkers for the clinical differential diagnosis in traumatic brain injury--a systematic review.Integration of proteomics, bioinformatics, and systems biology in traumatic brain injury biomarker discovery.The challenge of mild traumatic brain injury: role of biochemical markers in diagnosis of brain damage.Monitoring biomarkers of cellular injury and death in acute brain injury.Biomarkers in traumatic brain injury: a review.Comparing Plasma Phospho Tau, Total Tau, and Phospho Tau-Total Tau Ratio as Acute and Chronic Traumatic Brain Injury Biomarkers.Preliminary findings on biomarker levels from extracerebral sources in patients undergoing trauma surgery: Potential implications for TBI outcome studies.Biomarkers of Traumatic Brain Injury: Temporal Changes in Body FluidsCitrate-capped gold nanoparticles for the label-free detection of ubiquitin C-terminal hydrolase-1.
P2860
Q23920632-C0EF9BD4-69AD-4D9B-A018-43DB76B6E188Q26749435-3E843920-7344-45F5-A0F5-39970470AAE4Q26765302-3B93FB62-E0F7-417C-B235-F9C2086497B2Q26824124-78AA9077-69B5-4591-8E5A-A8E4E3C9196AQ27331576-A9B8A610-532A-46C9-966C-E332DA2D331BQ28066813-9211A41D-60D1-4E06-B20C-09474AA945E4Q31119100-056BC9B4-D995-4C85-8714-D9473876FE48Q33752053-7A8EAC77-54DD-428E-96E1-15DA608E7C3DQ33863821-047B23E1-753B-4910-989B-F1B410410F93Q33916315-9C071D1C-AD20-40B1-8F76-FE315C90747AQ34397124-5909A52C-A964-41A1-B2BF-1DB4ACFCDA20Q35131093-C14ED809-82B3-4DC5-886F-42CC12E8E058Q35179591-FF72C4E9-D93B-4C1B-9057-AC637B10783AQ35681358-7A46216A-3B68-4CBE-A994-90B6CB932A32Q35709639-1CE7EB47-C0C3-4ABC-82D7-F1663A41EC80Q35783757-337A1982-ACBA-4971-ADCF-A2BA572637E2Q35850990-F9E2A120-F4DE-4764-9DAB-F4B753F51946Q35857628-62544F30-FFEE-4DB7-BFA6-2F7E7B84D1C0Q35886747-93E3198A-9B02-4BBB-85AC-CBB29CB8CE4AQ35993214-E7AF8496-DC4A-4F3D-87BE-FC85B1DACB14Q36026050-D636EB97-E165-4165-B416-DF01827A1C49Q36131599-AD100F13-268E-47DE-A70C-70921833A9FBQ36387457-A036843A-722C-49DD-996F-7918B123DEBBQ36768885-9B13C4D6-F23C-461E-91BD-C3FB445BA69CQ36796090-A8EF6978-28F5-4159-8C24-75EDEC87C4F9Q36920836-D6E422BD-9697-4877-856A-4539A6930D77Q37019440-37B1896A-520F-4BBA-8323-FDB9F6684907Q37061236-3372F3A9-D250-46E8-B7D0-355E33D5CABCQ37430560-5C985B27-741C-411E-A149-BAD2D6C26A4FQ37590627-1638A56A-1713-4719-8CC6-1353749C02CCQ38027436-B5F08735-D437-47AC-AA55-AE6D966D7BF6Q38109663-27DEC772-70F7-4D09-90EF-93FD9BAB2E35Q38113215-5B73B360-EDD7-447B-B6C3-2B51D04A4AAAQ38118282-A992BF08-5CBD-4B91-AF36-03F235EB0CE9Q38248158-FF77DD75-A5EF-4440-86F7-C28F35BBD5CEQ38623128-8EFBE5FB-5EC1-4102-81A9-F33A5C96B5B4Q38664719-94ADFE55-46D2-48D2-970E-68BEC3E1B7F4Q38854032-6019B234-1A02-4BBD-BE74-6CBFDBFBDD42Q39061827-F46F8C16-C31D-4D8E-8D2A-1F07ABDB534CQ41679939-461C03DE-FE58-4E7E-82D3-34339233ADA6
P2860
Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Biokinetic analysis of ubiquit ...... brain injury patient biofluids
@ast
Biokinetic analysis of ubiquit ...... brain injury patient biofluids
@en
type
label
Biokinetic analysis of ubiquit ...... brain injury patient biofluids
@ast
Biokinetic analysis of ubiquit ...... brain injury patient biofluids
@en
prefLabel
Biokinetic analysis of ubiquit ...... brain injury patient biofluids
@ast
Biokinetic analysis of ubiquit ...... brain injury patient biofluids
@en
P2093
P2860
P50
P356
P1476
Biokinetic analysis of ubiquit ...... brain injury patient biofluids
@en
P2093
Andras Buki
Andrea Gabrielli
Claudia Robertson
Frank C Tortella
Joseph Tepas
Linda Papa
Ronald L Hayes
Steven A Robicsek
P2860
P304
P356
10.1089/NEU.2010.1564
P577
2011-04-08T00:00:00Z